Navigation Links
Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes

INDIANAPOLIS and BENTONVILLE, Ark., June 22 /PRNewswire-FirstCall/ -- Walmart (NYSE: WMT) and Eli Lilly and Company (NYSE: LLY) announced today they're teaming up to provide an affordable insulin option for people with diabetes.  

Beginning in mid-September, Lilly's Humulin® brand of insulin will be available in Walmart pharmacies across the U.S. under the dual-branded name Humulin® ReliOn®, including 10 mL vials of Humulin® R U-100, Humulin® N, and Humulin® 70/30 formulations.

Nearly 24 million Americans have diabetes, up from 21 million in 2005, according to the American Diabetes Association. Of those, about a quarter (27 percent) use insulin to manage blood sugar levels.(1)

"With diabetes reaching epidemic proportions in America, it's more important than ever for participants in the healthcare system to work together to provide solutions to help people successfully manage this condition," said Keith Johns, Lilly's senior director for insulins in the U.S. "At Lilly, we strive to provide innovative, cost-effective therapies that help patients manage their diabetes. And as the nation's largest retailer, Walmart touches more consumers than any other retail organization in the country. This collaboration offers a unique opportunity to provide a low-cost therapy to large numbers of people affected by diabetes."

Walmart has been a leader in providing quality, low-cost healthcare products to patients, pioneering and expanding access to affordable medications.

Along with Humulin® ReliOn® insulin, Walmart also offers $9 diabetes management products, including the ReliOn Ultima Blood Glucose Meter, the ReliOn Ultima Blood Glucose Test Strips (20 ct) and the ReliOn A1c test (glycated hemoglobin).

"Our ReliOn diabetes management products offer customers access to quality, affordable products that allow our customers to save money and live better, healthier lives," said Sandy Kinsey, Walmart's Vice President, Pharmacy Merchandising, Health and Wellness. "With this new offering of Humulin ReliOn insulin, Walmart underscores our commitment to helping people affected by diabetes manage their healthcare needs."

Humulin is the world's first synthetic human insulin. Its introduction by Lilly in 1982 revolutionized the treatment of diabetes by providing a biosynthetic version of human insulin, a naturally occurring hormone produced by the pancreas that regulates blood sugar but is diminished or absent in people with diabetes.

Humulin Safety Information

Any change of insulin should be made cautiously and only under medical supervision. Changes in strength, manufacturer, type, species, or method of manufacture may result in the need for a change in dosage.

About Lilly Diabetes

For more than 85 years, Eli Lilly and Company has been a worldwide leader in pioneering industry-leading solutions to support people living with and treating diabetes. Lilly introduced the world's first commercial insulin in 1923, and remains at the forefront of medical and delivery device innovation to manage diabetes. Lilly is also committed to providing solutions beyond therapy – practical tools, education, and support programs to help overcome barriers to success along the diabetes journey. At Lilly, the journey of each person living with or treating diabetes inspires ours. For more information, visit

About Eli Lilly and Company

Eli Lilly and Company, a leading innovation-driven company, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Information about Lilly is available at

About Walmart

Wal-Mart Stores, Inc. (NYSE: WMT), or "Walmart," serves customers and members more than 200 million times per week at more than 8,400 retail units under 55 different banners in 15 countries. With fiscal year 2010 sales of $405 billion, Walmart employs more than 2 million associates worldwide. A leader in sustainability, corporate philanthropy and employment opportunity, Walmart ranked first among retailers in Fortune Magazine's 2009 Most Admired Companies survey. Additional information about Walmart can be found by visiting and on Twitter at  Online merchandise sales are available at and

Humulin® is a trademark of Eli Lilly and Company.

Other trademarked names mentioned herein are the trademarks of their respective owners.


(1) Centers for Disease Control, National Diabetes Fact Sheet,  


(Logo: )

(Logo: )

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Declares Third-Quarter 2010 Dividend
2. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
3. Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
4. Lilly to Acquire Global License to AXIRON Testosterone Solution From Acrux
5. Lillys Online, Interactive Health Education Program Receives Two Web Awards
6. Lilly Reports Fourth-Quarter and Full-Year 2009 Results
7. Lilly Confirms Date and Conference Call For Fourth-Quarter and Full-Year 2009 Financial Results Announcement
8. Lilly CEO Stresses Human Element in Driving Medical Innovation
9. Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
10. PDL BioPharma Announces New Licensing Agreement With Eli Lilly
11. Lilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapies
Post Your Comments:
(Date:10/8/2015)... Oct. 8, 2015  Allergan plc (NYSE: AGN ... it will hold its R&D Day on November 4, ... – to 1:00 p.m. PT). The company will also ... at 9:00 a.m. ET (6:00 a.m. PT). ... --> Logo - ...
(Date:10/8/2015)... CAMBRIDGE, Mass. , Oct. 8, 2015 /PRNewswire/ ... has awarded approximately $40 million to the Broad ... whole genome sequencing of 20,000 individuals, as well ... sequencing and metabolite profiling. Trans-Omics for ... an initial step toward a larger initiative, which ...
(Date:10/8/2015)... FRANCISCO , Oct. 8, 2015  Nektar Therapeutics ... the Company,s pain and oncology portfolio during an Investor ... - 3:30 p.m. Eastern Time in New ... carcinoma.  Details of the NKTR-214 Phase 1/2 clinical program ... CD122-biased immune-stimulatory cytokine designed to preferentially stimulate the production ...
Breaking Medicine Technology:
... (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David ... be using the Roche LightCycler ® 480 System, a ... gene expression and genetic variation, in advanced cancer research. ... 480 System to support several key areas of research it ...
... 2011 /PRNewswire/ -- Royal Philips Electronics ... States availability of the Ingenia MRI system, the ... Previously available in Europe, Canada and Japan, the ... Food and Drug Administration. Driven by Philips commitment ...
Cached Medicine Technology:
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... company, has announced the final product specifications for TRACTUS, the world’s first sterile ... in the United States in response to the FDA’s recent Unique Device Identifier ...
(Date:10/9/2015)... ... October 09, 2015 , ... Cambias Insurance Agency, ... communities, is initiating a combined charity effort with Animal Rescue New Orleans in ... Louisiana. , Animal Rescue New Orleans is a non-profit organization committed to ...
(Date:10/9/2015)... ... , ... ViewPoint Center, a teen mental health hospital for youth ... stigma associated with mental illness causes many to hide away in shame rather than ... teens with mental illness , providing teens with comprehensive diagnostic assessment and treatment. ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... placement counseling, recently opened its newest office in Maryland – its Bethesda ... with a background as a project management technology consultant to many of the ...
(Date:10/9/2015)... Florida (PRWEB) , ... October 09, 2015 , ... A variety of race options will ... Treatment of Co-occurring Disorders on Sunday, October 18, at Al Lopez Park, 4810 North Himes ... and will include the choice of a 5K run or walk and a one-mile walk, ...
Breaking Medicine News(10 mins):
... to be used for treating patients with osteoporosis//, but scientists ... observe the changes in the bone mineral density. ,A ... drug strontium ranelate have an effect on the bone mineral ... advantage of the treatment procedure. The recent studies on the ...
... out that people who regularly drink large amount of alcohol are ... causes than binge drinkers, who drink a lot of alcohol in ... had more than enough attention given to young alcohol consumers who ... maximum, these people may be more at risk from violent assaults ...
... An interesting prospective study undertaken by the researchers at Massachusetts ... shown that higher intake of low-fat dairy may lower the ... II diabetes, either the body does not produce enough insulin ... the body to be able to use sugar. Type II ...
... have shown that placebo treatment can reduce the nature ... experiences. ,Placebo treatment consists of dummy medication or ... tablets, saline water injections etc. ,In the new ... have shown that placebo treatment can effectively control the ...
... said that stomach infections caused by Helicobacter pylori ... ,Helicobacter pylori are common bacteria that reside ... causes stomach infections. Previous research had connected the ... tracts, and ischemic heart disease. ,Researchers have ...
... the proper structure// and function of cell membranes and ... animal studies have shown that high intake of polyunsaturated ... is a clouding of the normally clear lens of ... of blindness in the world today. Besides the physical ...
Cached Medicine News:
CDIs new improved Implant Stabilizer has super-soft elastic bands with lace trim....
Bras and Breast Support...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
Medicine Products: